Abstract
Nonconvulsive electrotherapy (NET) defined as electrical brain stimulation administered like standard electroconvulsive therapy (ECT), but below seizure threshold, could be effective for patients with treatment-refractory depression (TRD) with fewer adverse neurocognitive outcomes. However, there is a lack of studies in Chinese patients with TRD. Thus, this study was conducted to examine the efficacy and safety of adjunctive NET for Chinese patients with TRD. Twenty TRD patients were enrolled and underwent six NET treatments. Depressive symptoms, response, and remission were assessed with the 17-item Hamilton Depression Rating Scale (HAMD-17) at baseline and after 1, 3, and 6 NET treatments. Neurocognitive function was assessed by the Wisconsin Card Sorting Test (WCST) at baseline and after the completion of six NET treatments. Mean HAMD-17 scores declined significantly from 26.2 to 10.4 (p < 0.001) after post-NET. The rates of response and remission were 60.0% (95% CI: 36.5–83.5) and 10.0% (95% CI: 0–24.4), respectively. Neurocognitive performance improved following a course of NET. No significant association was found between changes in depressive symptoms and baseline neurocognitive function. Adjunctive NET appeared to be effective for patients with TRD, without adverse neurocognitive effects. Randomized controlled studies were warranted to confirm these findings.
Similar content being viewed by others
References
Whiteford HA, Degenhardt L, Rehm J, Baxter AJ, Ferrari AJ, Erskine HE, et al. Global burden of disease attributable to mental and substance use disorders: findings from the global burden of disease study 2010. Lancet. 2013;382(9904):1575–86. https://doi.org/10.1016/s0140-6736(13)61611-6.
Voineskos D, Daskalakis ZJ, Blumberger DM. Management of treatment-resistant depression: challenges and strategies. Neuropsychiatr Dis Treat. 2020;16:221–34. https://doi.org/10.2147/ndt.s198774.
Strawn JR, Croarkin PE. Commentary: treatment failure and success: a commentary on defining and treating pediatric treatment-resistant depression - reflections on Dwyer et al. (2020). J Child Psychol Psychiatry. 2020;61:333–5. https://doi.org/10.1111/jcpp.13207.
Galling B, Calsina Ferrer A, Abi Zeid Daou M, Sangroula D, Hagi K, Correll CU. Safety and tolerability of antidepressant co-treatment in acute major depressive disorder: results from a systematic review and exploratory meta-analysis. Expert Opin Drug Saf. 2015;14(10):1587–608. https://doi.org/10.1517/14740338.2015.1085970.
Gerhard T, Stroup TS, Correll CU, Huang C, Tan Z, Crystal S, et al. Antipsychotic medication treatment patterns in adult depression. J Clin Psychiatry. 2018;79(2). https://doi.org/10.4088/JCP.16m10971.
Solmi M, Veronese N, Zaninotto L, van der Loos ML, Gao K, Schaffer A, et al. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials. CNS Spectr. 2016;21(5):403–18.
Davies P, Ijaz S, Williams CJ, Kessler D, Lewis G, Wiles N. Pharmacological interventions for treatment-resistant depression in adults. Cochrane Database Syst Rev. 2019;12:Cd010557. https://doi.org/10.1002/14651858.CD010557.pub2.
Zheng W, Cai DB, Xiang YQ, Zheng W, Jiang WL, Sim K, et al. Adjunctive intranasal esketamine for major depressive disorder: a systematic review of randomized double-blind controlled-placebo studies. J Affect Disord. 2020;265:63–70. https://doi.org/10.1016/j.jad.2020.01.002.
Zheng W, Zhou YL, Liu WJ, Wang CY, Zhan YN, Li HQ, et al. Investigation of medical effect of multiple ketamine infusions on patients with major depressive disorder. J Psychopharmacol (Oxford, England). 2019;33(4):494–501. https://doi.org/10.1177/0269881119827811.
Zheng W, Zhou YL, Liu WJ, Wang CY, Zhan YN, Li HQ, et al. Rapid and longer-term antidepressant effects of repeated-dose intravenous ketamine for patients with unipolar and bipolar depression. J Psychiatr Res. 2018;106:61–8. https://doi.org/10.1016/j.jpsychires.2018.09.013.
Wang Y, Shi YH, Xu Z, Fu H, Zeng H, Zheng GQ. Efficacy and safety of Chinese herbal medicine for depression: a systematic review and meta-analysis of randomized controlled trials. J Psychiatr Res. 2019;117:74–91. https://doi.org/10.1016/j.jpsychires.2019.07.003.
Gellersen HM, Kedzior KK. Antidepressant outcomes of high-frequency repetitive transcranial magnetic stimulation (rTMS) with F8-coil and deep transcranial magnetic stimulation (DTMS) with H1-coil in major depression: a systematic review and meta-analysis. BMC Psychiatry. 2019;19(1):139. https://doi.org/10.1186/s12888-019-2106-7.
Wang J, Vila-Rodriguez F, Ge R, Gao S, Gregory E, Jiang W, et al. Accelerated magnetic seizure therapy (aMST) for treatment of major depressive disorder: a pilot study. J Affect Disord. 2020;264:215–20. https://doi.org/10.1016/j.jad.2019.12.022.
Kayser S, Bewernick BH, Wagner S, Schlaepfer TE. Effects of magnetic seizure therapy on anterograde and retrograde amnesia in treatment-resistant depression. Depress Anxiety. 2020;37(2):125–33. https://doi.org/10.1002/da.22958.
Kisely S, Li A, Warren N, Siskind D. A systematic review and meta-analysis of deep brain stimulation for depression. Depress Anxiety. 2018;35(5):468–80. https://doi.org/10.1002/da.22746.
Dandekar MP, Fenoy AJ, Carvalho AF, Soares JC, Quevedo J. Deep brain stimulation for treatment-resistant depression: an integrative review of preclinical and clinical findings and translational implications. Mol Psychiatry. 2018;23(5):1094–112. https://doi.org/10.1038/mp.2018.2.
Zhou C, Zhang H, Qin Y, Tian T, Xu B, Chen J, et al. A systematic review and meta-analysis of deep brain stimulation in treatment-resistant depression. Prog Neuro-Psychopharmacol Biol Psychiatry. 2018;82:224–32. https://doi.org/10.1016/j.pnpbp.2017.11.012.
Bahji A, Hawken ER, Sepehry AA, Cabrera CA, Vazquez G. ECT beyond unipolar major depression: systematic review and meta-analysis of electroconvulsive therapy in bipolar depression. Acta Psychiatr Scand. 2019;139(3):214–26. https://doi.org/10.1111/acps.12994.
Regenold WT, Noorani RJ, Piez D, Patel P. Nonconvulsive electrotherapy for treatment resistant unipolar and bipolar major depressive disorder: a proof-of-concept trial. Brain Stimul. 2015;8(5):855–61. https://doi.org/10.1016/j.brs.2015.06.011.
Perciaccante A, Coralli A, Cambioli L, Riva MA. Nonconvulsive electrotherapy in psychiatry: the treatment of the mental disorders of the Norwegian painter Edvard munch. Bipolar Disord. 2017;19(2):72–3. https://doi.org/10.1111/bdi.12483.
Gersner R, Toth E, Isserles M, Zangen A. Site-specific antidepressant effects of repeated subconvulsive electrical stimulation: potential role of brain-derived neurotrophic factor. Biol Psychiatry. 2010;67(2):125–32. https://doi.org/10.1016/j.biopsych.2009.09.015.
Beran M, Perkins JC, Scollon RW. Psychological studies on patients undergoing nonconvulsive electric-stimulation treatment. Am J Psychiatry. 1952;109(5):367–74. https://doi.org/10.1176/ajp.109.5.367.
Alexander L. Nonconvulsive electric stimulation therapy; its place in the treatment of affective disorders, with notes on the reciprocal relationship of anxiety and depression. Am J Psychiatry. 1950;107(4):241–50. https://doi.org/10.1176/ajp.107.4.241.
Olkon DM. Subconvulsive electrotherapy in mental disorders. Dis Nerv Syst. 1957;18(7 Part 1):271.
Prudic J, Sackeim HA, Devanand DP, Krueger RB, Settembrino JM. Acute cognitive effects of subconvulsive electrical stimulation. Convuls Ther. 1994;10(1):4–24.
Krystal AD, Weiner RD. ECT seizure therapeutic adequacy. Convuls Ther. 1994;10(2):153–64.
Crow TJ. The scientific status of electro-convulsive therapy. Psychol Med. 1979;9(3):401–8. https://doi.org/10.1017/s0033291700031937.
Post RM, Kimbrell TA, McCann U, Dunn RT, George MS, Weiss SR. Are convulsions necessary for the antidepressive effect of electroconvulsive therapy: outcome of repeated transcranial magnetic stimulation. L'Encephale. 1997;23(Spec No 3):27–35.
APA. American Psychiatric Association: structured clinical interview for DSM-IV. Washington, DC: American Psychiatric Press; 1994.
Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56–62. https://doi.org/10.1136/jnnp.23.1.56.
Heijnen WT, Birkenhager TK, Wierdsma AI, van den Broek WW. Antidepressant pharmacotherapy failure and response to subsequent electroconvulsive therapy: a meta-analysis. J Clin Psychopharmacol. 2010;30(5):616–9. https://doi.org/10.1097/JCP.0b013e3181ee0f5f.
Lin CH, Chen MC, Yang WC, Lane HY. Early improvement predicts outcome of major depressive patients treated with electroconvulsive therapy. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. 2016;26(2):225–33. https://doi.org/10.1016/j.euroneuro.2015.12.019.
Lin HS, Lin CH. Early improvement in HAMD-17 and HAMD-6 scores predicts ultimate response and remission for depressed patients treated with fluoxetine or ECT. J Affect Disord. 2019;245:91–7. https://doi.org/10.1016/j.jad.2018.10.105.
Channon S. Executive dysfunction in depression: the Wisconsin card sorting test. J Affect Disord. 1996;39(2):107–14. https://doi.org/10.1016/0165-0327(96)00027-4.
Berman RM, Prudic J, Brakemeier EL, Olfson M, Sackeim HA. Subjective evaluation of the therapeutic and cognitive effects of electroconvulsive therapy. Brain Stimul. 2008;1(1):16–26. https://doi.org/10.1016/j.brs.2007.08.005.
Wang G, Zheng W, Li XB, Wang SB, Cai DB, Yang XH, et al. ECT augmentation of clozapine for clozapine-resistant schizophrenia: a meta-analysis of randomized controlled trials. J Psychiatr Res. 2018;105:23–32. https://doi.org/10.1016/j.jpsychires.2018.08.002.
Lara E, Olaya B, Garin N, Ayuso-Mateos JL, Miret M, Moneta V, et al. Is cognitive impairment associated with suicidality? A population-based study. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. 2015;25(2):203–13. https://doi.org/10.1016/j.euroneuro.2014.08.010.
Bjolseth TM, Engedal K, Benth JS, Dybedal GS, Gaarden TL, Tanum L. Baseline cognitive function does not predict the treatment outcome of electroconvulsive therapy (ECT) in late-life depression. J Affect Disord. 2015;185:67–75. https://doi.org/10.1016/j.jad.2015.06.021.
Alexopoulos GS. "The depression-executive dysfunction syndrome of late life": a specific target for D3 agonists? The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 2001;9(1):22–9.
McLennan SN, Mathias JL. The depression-executive dysfunction (DED) syndrome and response to antidepressants: a meta-analytic review. Int J Geriatr Psychiatry. 2010;25(10):933–44. https://doi.org/10.1002/gps.2431.
Basagni B, Errante A, Pinardi C, De Gaetano K, Crisi G, De Tanti A, et al. Rehabilitation of unilateral spatial neglect: a combined behavioral and fMRI single-case study. Neuropsychology. 2019;33(3):343–57. https://doi.org/10.1037/neu0000523.
Uddin M. Blood-based biomarkers in depression: emerging themes in clinical research. Mol Diagn Ther. 2014;18(5):469–82. https://doi.org/10.1007/s40291-014-0108-1.
Kambeitz J, Cabral C, Sacchet MD, Gotlib IH, Zahn R, Serpa MH, et al. Detecting neuroimaging biomarkers for depression: a meta-analysis of multivariate pattern recognition studies. Biol Psychiatry. 2017;82(5):330–8. https://doi.org/10.1016/j.biopsych.2016.10.028.
Cook IA, Hunter AM, Gilmer WS, Iosifescu DV, Zisook S, Burgoyne KS, et al. Quantitative electroencephalogram biomarkers for predicting likelihood and speed of achieving sustained remission in major depression: a report from the biomarkers for rapid identification of treatment effectiveness in major depression (BRITE-MD) trial. J Clin Psychiatry. 2013;74(1):51–6. https://doi.org/10.4088/JCP.10m06813.
Acknowledgements
This study was funded by the Science and Technology Planning Project of Guangdong Province (B2016109), the Science and Technology Plan Project of Guangdong Province (2019B030316001), and Guangzhou Clinical Characteristic Technology Project (2019TS67).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of Interest
The authors have no conflicts of interest concerning this article.
Human and Animal Rights
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed Consent
NA.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(DOCX 19 kb)
Rights and permissions
About this article
Cite this article
Zheng, W., Jiang, ML., He, HB. et al. A Preliminary Study of Adjunctive Nonconvulsive Electrotherapy for Treatment-Refractory Depression. Psychiatr Q 92, 311–320 (2021). https://doi.org/10.1007/s11126-020-09798-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11126-020-09798-3